Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Bioequivalence of Eldecalcitol in Healthy Chinese Subjects
NCT05406050Phase 1Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Oct 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eldecalcitol in osteoporosis (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Peak Plasma Concentration, Area under the plasma concentration versus time curve (AUC0-t) and 2 more. Started Oct 2020; status: completed.
02
Drugs
eldecalcitol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05406050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05406050.